Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic

In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports Vol. 13; no. 1; pp. 712 - 5
Main Authors: Guedes, Ana Rubia, Oliveira, Maura S., Tavares, Bruno M., Luna-Muschi, Alessandra, Lazari, Carolina dos Santos, Montal, Amanda C., de Faria, Elizabeth, Maia, Fernando Liebhart, Barboza, Antonio dos Santos, Leme, Mariana Deckers, Tomazini, Francis M., Costa, Silvia Figueiredo, Levin, Anna S.
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 13.01.2023
Nature Publishing Group
Nature Portfolio
Subjects:
ISSN:2045-2322, 2045-2322
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p  < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases.
AbstractList In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital's Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases.In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital's Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases.
In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases.
In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p  < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases.
In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases.
Abstract In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases.
ArticleNumber 712
Author Tomazini, Francis M.
de Faria, Elizabeth
Luna-Muschi, Alessandra
Levin, Anna S.
Lazari, Carolina dos Santos
Tavares, Bruno M.
Guedes, Ana Rubia
Barboza, Antonio dos Santos
Oliveira, Maura S.
Leme, Mariana Deckers
Maia, Fernando Liebhart
Costa, Silvia Figueiredo
Montal, Amanda C.
Author_xml – sequence: 1
  givenname: Ana Rubia
  orcidid: 0000-0002-6358-2912
  surname: Guedes
  fullname: Guedes, Ana Rubia
  organization: Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 2
  givenname: Maura S.
  surname: Oliveira
  fullname: Oliveira, Maura S.
  organization: Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 3
  givenname: Bruno M.
  surname: Tavares
  fullname: Tavares, Bruno M.
  organization: Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 4
  givenname: Alessandra
  surname: Luna-Muschi
  fullname: Luna-Muschi, Alessandra
  organization: Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo, Department of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo
– sequence: 5
  givenname: Carolina dos Santos
  surname: Lazari
  fullname: Lazari, Carolina dos Santos
  organization: Central Laboratory Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 6
  givenname: Amanda C.
  surname: Montal
  fullname: Montal, Amanda C.
  organization: Central Administration of Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 7
  givenname: Elizabeth
  surname: de Faria
  fullname: de Faria, Elizabeth
  organization: Central Administration of Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 8
  givenname: Fernando Liebhart
  surname: Maia
  fullname: Maia, Fernando Liebhart
  organization: Healthcare Worker Health Services, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 9
  givenname: Antonio dos Santos
  surname: Barboza
  fullname: Barboza, Antonio dos Santos
  organization: Healthcare Worker Health Services, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 10
  givenname: Mariana Deckers
  surname: Leme
  fullname: Leme, Mariana Deckers
  organization: Healthcare Worker Health Services, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 11
  givenname: Francis M.
  surname: Tomazini
  fullname: Tomazini, Francis M.
  organization: Central Administration of Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo
– sequence: 12
  givenname: Silvia Figueiredo
  surname: Costa
  fullname: Costa, Silvia Figueiredo
  email: silviacosta@usp.br
  organization: Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo, Department of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo
– sequence: 13
  givenname: Anna S.
  orcidid: 0000-0003-2427-8368
  surname: Levin
  fullname: Levin, Anna S.
  organization: Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo, Department of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36639411$$D View this record in MEDLINE/PubMed
BookMark eNp9Ut1uFCEYnZga-2NfwAtD4o03o8AwA9yYmK3VTZo0MWriFWHgY5d1FlaYrenb-Cw-mexOrW0vyg0fcM7hwHeOq4MQA1TVC4LfENyIt5mRVooaU1rTVmJRd0-qI4pZW9OG0oM79WF1mvMKl9FSyYh8Vh02XdeUkhxV3z-DDw7M6GNASY-AfEAambiMaUTRoSXoYVwanQD9iukHpIziFSRE__y-Br1bOTQuAc0uv83PaiLRRgcLa2-eV0-dHjKc3swn1dfzD19mn-qLy4_z2fuL2rQMjzUI2VjSU8Z6YQzmrhGtI1rqjlhMGTYYeC-xZY5rRx1I0nHSSWscZWBb15xU80nXRr1Sm-TXOl2rqL3ab8S0UDqN3gyghOGkxbIDazUDh6Ug1PbGCMd5TwUUrXeT1mbbr8EaCGPSwz3R-yfBL9UiXikpGs5bUgRe3wik-HMLeVRrnw0Mgw4Qt1lR3rWcl4bxAn31ALqK2xTKV-1RlEnZyIJ6edfRrZV_HSwAOgFMijkncLcQgtUuKWpKiipJUfukqK6QxAOS8aPeZaC8yg-PU5uJmss9YQHpv-1HWH8Bp-_SEg
CitedBy_id crossref_primary_10_1002_hsr2_71254
crossref_primary_10_1016_j_heliyon_2024_e26619
crossref_primary_10_3390_v15102100
crossref_primary_10_1590_s1678_9946202567033
crossref_primary_10_1186_s44263_025_00189_z
crossref_primary_10_3390_jpm13101474
crossref_primary_10_1038_d41586_023_01371_9
crossref_primary_10_3389_fpubh_2023_1290402
crossref_primary_10_3390_ijerph20043335
crossref_primary_10_3389_fimmu_2024_1344086
crossref_primary_10_3389_fpubh_2025_1521658
crossref_primary_10_2196_63190
crossref_primary_10_1186_s12879_024_09225_z
crossref_primary_10_1093_bfgp_elad051
crossref_primary_10_1186_s12879_024_09221_3
crossref_primary_10_3390_healthcare11081077
crossref_primary_10_7189_jogh_13_06051
crossref_primary_10_3390_v15071551
crossref_primary_10_7759_cureus_61470
crossref_primary_10_1002_pcn5_70017
crossref_primary_10_3390_vaccines12060682
crossref_primary_10_3389_fdata_2023_1355080
crossref_primary_10_1038_s41598_025_89472_5
crossref_primary_10_1142_S021833902550010X
crossref_primary_10_1007_s13762_024_05665_x
crossref_primary_10_1371_journal_pone_0303813
crossref_primary_10_3390_computation13050113
crossref_primary_10_1001_jamanetworkopen_2023_9840
crossref_primary_10_1002_hsr2_2016
crossref_primary_10_3390_jcm12113861
crossref_primary_10_1007_s42770_024_01467_y
crossref_primary_10_1177_21650799231212898
crossref_primary_10_1186_s12884_024_06657_y
crossref_primary_10_3389_fpubh_2023_1321283
crossref_primary_10_1017_S0950268824000487
crossref_primary_10_3390_v15040967
crossref_primary_10_3390_ijms25158155
crossref_primary_10_3390_vaccines11030626
crossref_primary_10_1038_s41598_023_41841_8
crossref_primary_10_1080_23744235_2024_2367112
crossref_primary_10_3390_vaccines13080815
Cites_doi 10.1016/S1473-3099(22)00069-X
10.1016/S0140-6736(21)00183-5
10.1016/S0140-6736(21)00575-4
10.1056/NEJMoa2118946
10.1016/j.cmi.2021.07.030
10.1016/j.cll.2021.10.004
10.1111/eci.13520
10.1093/cid/ciaa1845
10.2807/1560-7917.ES.2020.25.3.20000459-
10.1016/j.envres.2022.112911
10.1093/cid/ciab952
10.15585/mmwr.mm7115e2
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.1038/s41598-022-25908-6
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Open Access: DOAJ - Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
CrossRef

Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 5
ExternalDocumentID oai_doaj_org_article_8c715096edda4ef09812dbcc8f77b28e
PMC9837751
36639411
10_1038_s41598_022_25908_6
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Brazil
GeographicLocations_xml – name: Brazil
GrantInformation_xml – fundername: Itaú Unibanco “Todos pela saúde” program.
– fundername: ;
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFFHD
AFPKN
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c540t-e893d1b244b8cc07f385f1a9a61d0240c0e7b90d4f7af2fe9167169dcf24ed5f3
IEDL.DBID M2P
ISICitedReferencesCount 50
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000968670400015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2045-2322
IngestDate Tue Oct 14 18:42:11 EDT 2025
Tue Nov 04 02:06:31 EST 2025
Thu Oct 02 11:27:30 EDT 2025
Tue Oct 07 07:46:51 EDT 2025
Thu Apr 03 07:02:41 EDT 2025
Sat Nov 29 02:07:50 EST 2025
Tue Nov 18 22:04:21 EST 2025
Fri Feb 21 02:39:37 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-e893d1b244b8cc07f385f1a9a61d0240c0e7b90d4f7af2fe9167169dcf24ed5f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2427-8368
0000-0002-6358-2912
OpenAccessLink https://www.proquest.com/docview/2765249939?pq-origsite=%requestingapplication%
PMID 36639411
PQID 2765249939
PQPubID 2041939
PageCount 5
ParticipantIDs doaj_primary_oai_doaj_org_article_8c715096edda4ef09812dbcc8f77b28e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9837751
proquest_miscellaneous_2765772597
proquest_journals_2765249939
pubmed_primary_36639411
crossref_primary_10_1038_s41598_022_25908_6
crossref_citationtrail_10_1038_s41598_022_25908_6
springer_journals_10_1038_s41598_022_25908_6
PublicationCentury 2000
PublicationDate 2023-01-13
PublicationDateYYYYMMDD 2023-01-13
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-13
  day: 13
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2023
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Costa, Giavina-Bianchi, Buss (CR7) 2021; 73
CR2
Akinbami, Biggerstaff, Chan, McGibbon, Pathela, Petersen (CR4) 2022; 75
Sabino, Buss, Carvalho, Prete, Crispim, Fraiji, Pereira, Parag, Peixoto, Kraemer, Oikawa, Salomon, Cucunuba, Castro, Santos, Nascimento, Pereira, Ferguson, Pybus, Kucharski, Busch, Dye, Faria (CR6) 2021; 397
Cohen, Kleynhans, von Gottberg (CR10) 2022; 22
Plumb, Feldstein, Barkley (CR5) 2022; 71
Slezak, Bruxvoort, Fischer, Broder, Ackerson, Tartof (CR8) 2021; 27
CR15
Pilz, Theiler-Schwetz, Trummer, Krause, Ioannidis (CR3) 2022; 8
CR13
Corman, Landt, Kaiser (CR14) 2020; 25
Zuiani, Wesemann (CR1) 2022; 42
Hansen, Michlmayr, Gubbels, Mølbak, Ethelberg (CR11) 2021; 397
Goldberg, Mandel, Bar-On (CR12) 2022; 386
Pilz, Chakeri, Ioannidis (CR9) 2021; 51
A Zuiani (25908_CR1) 2022; 42
ID Plumb (25908_CR5) 2022; 71
S Pilz (25908_CR9) 2021; 51
C Cohen (25908_CR10) 2022; 22
LJ Akinbami (25908_CR4) 2022; 75
J Slezak (25908_CR8) 2021; 27
25908_CR13
S Pilz (25908_CR3) 2022; 8
25908_CR2
25908_CR15
SF Costa (25908_CR7) 2021; 73
CH Hansen (25908_CR11) 2021; 397
EC Sabino (25908_CR6) 2021; 397
VM Corman (25908_CR14) 2020; 25
Y Goldberg (25908_CR12) 2022; 386
References_xml – volume: 22
  start-page: 821
  issue: 6
  year: 2022
  end-page: 834
  ident: CR10
  article-title: SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: Results of the PHIRST-C cohort study, South Africa, 2020–21
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00069-X
– volume: 397
  start-page: 452
  year: 2021
  end-page: 455
  ident: CR6
  article-title: Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00183-5
– volume: 397
  start-page: 1204
  issue: 10280
  year: 2021
  end-page: 1212
  ident: CR11
  article-title: Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: A population-level observational study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00575-4
– volume: 386
  start-page: 2201
  issue: 23
  year: 2022
  end-page: 2212
  ident: CR12
  article-title: Protection and waning of natural and hybrid immunity to SARS-CoV-2
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2118946
– volume: 27
  start-page: 1860.e7
  issue: 12
  year: 2021
  end-page: 1860.e10
  ident: CR8
  article-title: Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1016/j.cmi.2021.07.030
– ident: CR15
– ident: CR2
– volume: 42
  start-page: 85
  year: 2022
  end-page: 96
  ident: CR1
  article-title: Antibody dynamics and durability in coronavirus disease-19
  publication-title: Clin. Lab. Med.
  doi: 10.1016/j.cll.2021.10.004
– volume: 51
  start-page: e13520
  issue: 4
  year: 2021
  ident: CR9
  article-title: SARS-CoV-2 re-infection risk in Austria
  publication-title: Eur. J. Clin. Investig.
  doi: 10.1111/eci.13520
– ident: CR13
– volume: 73
  start-page: e1214
  issue: 5
  year: 2021
  end-page: e1218
  ident: CR7
  article-title: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and risk factors among oligo/asymptomatic healthcare workers: Estimating the impact of community transmission
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa1845
– volume: 25
  start-page: 2000045
  issue: 3
  year: 2020
  ident: CR14
  article-title: Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. [Published correction appears in Euro Surveill. 2021 Feb;26(5)]
  publication-title: Euro Surveill.
  doi: 10.2807/1560-7917.ES.2020.25.3.20000459-
– volume: 8
  start-page: 112911
  issue: 209
  year: 2022
  ident: CR3
  article-title: SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
  publication-title: Environ. Res.
  doi: 10.1016/j.envres.2022.112911
– volume: 75
  start-page: e201
  issue: 1
  year: 2022
  end-page: e207
  ident: CR4
  article-title: Reinfection with severe acute respiratory syndrome coronavirus 2 among previously infected healthcare personnel and first responders
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciab952
– volume: 71
  start-page: 549
  issue: 15
  year: 2022
  end-page: 555
  ident: CR5
  article-title: Effectiveness of COVID-19 mRNA vaccination in preventing COVID-19-associated hospitalization among adults with previous SARS-CoV-2 infection—United States, June 2021–February 2022
  publication-title: MMWR Morb. Mortal. Wkly. Rep.
  doi: 10.15585/mmwr.mm7115e2
– volume: 71
  start-page: 549
  issue: 15
  year: 2022
  ident: 25908_CR5
  publication-title: MMWR Morb. Mortal. Wkly. Rep.
  doi: 10.15585/mmwr.mm7115e2
– volume: 397
  start-page: 1204
  issue: 10280
  year: 2021
  ident: 25908_CR11
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00575-4
– volume: 386
  start-page: 2201
  issue: 23
  year: 2022
  ident: 25908_CR12
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2118946
– volume: 8
  start-page: 112911
  issue: 209
  year: 2022
  ident: 25908_CR3
  publication-title: Environ. Res.
  doi: 10.1016/j.envres.2022.112911
– volume: 397
  start-page: 452
  year: 2021
  ident: 25908_CR6
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00183-5
– volume: 25
  start-page: 2000045
  issue: 3
  year: 2020
  ident: 25908_CR14
  publication-title: Euro Surveill.
  doi: 10.2807/1560-7917.ES.2020.25.3.20000459-
– ident: 25908_CR2
– volume: 75
  start-page: e201
  issue: 1
  year: 2022
  ident: 25908_CR4
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciab952
– volume: 42
  start-page: 85
  year: 2022
  ident: 25908_CR1
  publication-title: Clin. Lab. Med.
  doi: 10.1016/j.cll.2021.10.004
– ident: 25908_CR13
– volume: 73
  start-page: e1214
  issue: 5
  year: 2021
  ident: 25908_CR7
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa1845
– volume: 27
  start-page: 1860.e7
  issue: 12
  year: 2021
  ident: 25908_CR8
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1016/j.cmi.2021.07.030
– ident: 25908_CR15
– volume: 22
  start-page: 821
  issue: 6
  year: 2022
  ident: 25908_CR10
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(22)00069-X
– volume: 51
  start-page: e13520
  issue: 4
  year: 2021
  ident: 25908_CR9
  publication-title: Eur. J. Clin. Investig.
  doi: 10.1111/eci.13520
SSID ssj0000529419
Score 2.5802438
Snippet In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated...
In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated...
Abstract In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 712
SubjectTerms 631/326/2521
692/699/255/2514
Brazil - epidemiology
Coronaviruses
COVID-19
COVID-19 - epidemiology
Health care
Health Personnel
Humanities and Social Sciences
Humans
Medical personnel
multidisciplinary
Pandemics
Polymerase chain reaction
Reinfection - epidemiology
SARS-CoV-2 - genetics
Science
Science (multidisciplinary)
Severe acute respiratory syndrome coronavirus 2
SummonAdditionalLinks – databaseName: Open Access: DOAJ - Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxUxEA5SFHwR766tEsE3Dd0ku5vkUatFQaqIlvoUcqUHdE8557TQf-Nv8Zc5s9mz9nh98XUzgWEy2fkmmXxDyONa6hy0T8xk07Em-5ZpANZMOc6VdybpoU3n4Rt1cKCPjsy7C62-sCas0AMXw-3qoDhSlKQYXZNybSAiRR-Czkp5oRP-fWtlLiRThdVbmIab8ZUMKLS7hEiFr8kg9xLY55t1G5FoIOz_Hcr8tVjypxvTIRDtXyfXRgRJnxXNb5BLqb9JrpSekue3yKf3aV1g1VPkgaCznjqKjXAXKzrP9Hiq-KJYlAXwj2IZJxXfvp6D2y9RBlAh3Xt7-PoF44ae4Dnzl1m4TT7uv_yw94qN_RNYABy2YgmwSOQeArjXIdQqS91m7ozreERqs1An5U0dm6xcFjkBUkTunBiyaFJss7xDtvp5n-4R6kXd5i74rGDMa-N8h8E_Rt-13nNZEb62pQ0juTj2uPhsh0tuqW2xv4VZdrC_7SryZJpzUqg1_ir9HJdokkRa7OEDOIsdncX-y1kqsrNeYDvu1aUVqmshCTXSVOTRNAy7DK9OXJ_mp0UG8hDIvipyt_jDpIkE0AbOxiuiNjxlQ9XNkX52PDB5Gy2VamHm07VP_VDrz6a4_z9MsU2uCsBreJrE5Q7ZWi1O0wNyOZytZsvFw2E3fQeYfCKL
  priority: 102
  providerName: Directory of Open Access Journals
Title Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic
URI https://link.springer.com/article/10.1038/s41598-022-25908-6
https://www.ncbi.nlm.nih.gov/pubmed/36639411
https://www.proquest.com/docview/2765249939
https://www.proquest.com/docview/2765772597
https://pubmed.ncbi.nlm.nih.gov/PMC9837751
https://doaj.org/article/8c715096edda4ef09812dbcc8f77b28e
Volume 13
WOSCitedRecordID wos000968670400015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M7P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database (ProQuest)
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M2P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RLkhceBcCZWUkbhA1zsv2CdHSikp0WVVQLacoftGVILvsbpH675lxsqmWRy9cfIhtycnMxJ9nxt8AvEwy6Y3ULlZelXHudRFLBNaxqDkXulZOhjKdZx_EaCQnEzXuHG7LLq1y_U8MP2o7M-Qj30tFWeBRQWXqzfxHTFWjKLraldDYggEiG04pXSfpuPexUBQr56q7K4PL2lvifkV3yvAEllK177jc2I8Cbf_fsOafKZO_xU3DdnR0939f5B7c6YAoe9tqzn244ZoHcKstTXn5ECanbp2n1TCik2DThtWM6ukuVmzm2XmfOMYotwtRJKNsUJaySzSeJQ1BbMkOPp4dv4u5YnPyVn-fmkfw-ejw08H7uKvCEBtEc6vYIaKxXCMM0NKYRPhMFp7Xqi65JYI0kzihVWJzL2qfeod4kxh4rPFp7mzhsx3YbmaNewJMp0nhS6O9wD4tVa1LghDW6rLQmmcR8LUsKtNRlFOljG9VCJVnsmrlV-GsKsivKiN41c-ZtwQd147eJxH3I4lcOzyYLb5Wna1W0ghOrDjO2jp3PlEIgqw2RnohdCpdBLtryVadxS-rK7FG8KLvRlulAEzduNlFOwZPM3iGi-Bxq0_9SjKEfqisPAKxoWkbS93saabngQ9cyUyIAme-Xuvk1bL-_SmeXv8Wz-B2iniOvE0824Xt1eLCPYeb5udqulwMYUtMRGjlEAb7h6Px6TC4M4bBAqkV2A7GxyfjL78Ab1w1jA
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1JbxMxFLZKAcGFfRkoYCQ40VHHnsX2ASFoqRo1hAqVKrdhvNFIMAmZFJQ_xW_kvdmqsPTWA9fYjmzPW75nP3-PkGdRLL2R2oXKqyxMvE5DCcA6FAVjQhfKybpM59FQjEZyPFYHa-Rn9xYG0yo7m1gbajs1eEa-xUWWQqigYvVq9i3EqlF4u9qV0GjEYt8tf0DIVr0c7MD3fc757tvD7b2wrSoQGkAni9CBh7ZMg1vT0phI-FimnhWqyJhFwi8TOaFVZBMvCs-9A_yEjDLWeJ44m_oY_vcCuZggsximCvKD_kwHb80Sptq3ObANWxX4R3zDBhEfx-riYbbi_-oyAX_Dtn-maP52T1u7v93r_9vG3SDXWqBNXzeacZOsufIWudyU3lzeJuMPrstDKynSZdBJSQuK9YLnCzr19LhPjKOYuwYomWK2K-V0CYupsAtgZ7r9_miwEzJFZ3ga_3Vi7pCP57Ksu2S9nJbuPqGaR6nPjPYC2rRUhc4QIlmrs1RrFgeEdd8-Ny0FO1YC-ZLXqQCxzBt5yWFUXstLngXkRT9m1hCQnNn7DYpU3xPJw-sfpvPPeWuLcmkEQ9YfZ22ROB8pAHlWGyO9EJpLF5CNTpLy1qJV-akYBeRp3wy2CC-YitJNT5o-EK1BjBqQe4389jOJAdqCcrCAiBXJXpnqaks5Oa75zpWMhUhh5GanA6fT-vdWPDh7FU_Ilb3Dd8N8OBjtPyRXOWBXPFlj8QZZX8xP3CNyyXxfTKr541rHKfl03rrxC0ljjEo
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1JbxMxFH4qKSAu7MtAASPBiY4yns32ASFoiIhaQoSgCqdhvNFIMBOSFJS_xq_jebYqLL31wDW2I9vzlu_Zz-8DeBxE3CoujS-sSP3YysTnCKx9llPKZC4Mr2g6Dw_YeMynUzHZgp_tWxiXVtnaxMpQ61K5M_J-yNIEQwURib5t0iImg-Hz-TffMUi5m9aWTqMWkX2z_oHh2_LZaIDf-kkYDl-933vtNwwDvkKksvINemtNJbo4yZUKmI14Ymku8pRqV_xLBYZJEejYstyG1iCWctVltLJhbHRiI_zfc7CNkDwOe7A9Gb2ZfOxOeNwdWkxF81IHN6W_RG_pXrRh_Bc6rnE_3fCGFWnA35Dunwmbv93aVs5weOV_3sarcLmB4ORFrTPXYMsU1-FCTcq5vgHTd6bNUCuIK6RBZgXJiWMSXqxIaclRlzJHXFYb4mfi8mBJSNa4mKXrgqia7L09HA18KsjcndN_namb8OFMlnULekVZmDtAZBgkNlXSMmyTXOQydeBJa5kmUtLIA9rKQaaa4uyOI-RLViUJRDyrZSfDUVklO1nqwdNuzLwuTXJq75dOvLqerqx49UO5-Jw1VirjilFXD8honcfGBgLhn5ZKccuYDLnxYKeVqqyxdcvsRKQ8eNQ1o5VyV095Ycrjug_GcRi9enC7luVuJhGCXlQU6gHbkPKNqW62FLOjqhK64BFjCY7cbfXhZFr_3oq7p6_iIVxElcgORuP9e3ApRFDrjtxotAO91eLY3Ifz6vtqtlw8aBSewKezVo5fkHOWkw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reinfection+rate+in+a+cohort+of+healthcare+workers+over+2%C2%A0years+of+the+COVID-19+pandemic&rft.jtitle=Scientific+reports&rft.au=Guedes%2C+Ana+Rubia&rft.au=Oliveira%2C+Maura+S&rft.au=Tavares%2C+Bruno+M&rft.au=Luna-Muschi%2C+Alessandra&rft.date=2023-01-13&rft.eissn=2045-2322&rft.volume=13&rft.issue=1&rft.spage=712&rft_id=info:doi/10.1038%2Fs41598-022-25908-6&rft_id=info%3Apmid%2F36639411&rft.externalDocID=36639411
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon